Daily Bulletin

The Conversation

  • Written by The Conversation Contributor

Overnight, Maria Sharapova called a press conference to announce she had tested positive for a banned substance (mildronate) during this year’s Australian Open.

Originally, speculation had been that the press conference was to announce her retirement from tennis, but a failed drugs test may amount to the same thing. At the age of 28, and plagued by injuries for much of her career, a mandatory two-year ban (for the unknowing use of a banned substance, which might become four if “knowing” use is established) may prove too high a barrier to overcome.

Sharapova is the latest high-profile sportsperson to test positive to mildronate in the last month, following one of the best-known Russian figure skaters, Ekaterina Bobrova, and veteran cyclist Eduard Vorganov.

Sharapova tells a press conference she didn’t know the medication was banned.

What is mildronate?

Mildronate (also known as meldonium) has been a quiet secret in performance-enhancement circles for many years. This may be partly because most of the research on it was published in Russian and the drug is not commonly used outside Eastern Europe. After its development in Latvia in the 1970s, research was first published around ten years later and focused largely on the drug’s therapeutic potential for patients with heart muscle damage.

Technically, mildronate inhibits carnitine, an amino acid derivative that transports fatty acids into mitochondria (the “power houses” of a cell). Less carnitine means less utilisation of those fatty acids for fuel, which forces the body to burn carbohydrates for fuel. This is a far more efficient process than fatty oxidation, which is very “expensive” in the amount of oxygen it requires.

Mildronate is typically prescribed for angina (when the heart muscle doesn’t receive enough oxygen from the blood), as it reduces the overall oxygen consumption necessary. For athletes, though, this reduction in oxygen demand translates into an increase in performance – for instance, increased endurance and aerobic properties, and faster recovery. While there isn’t a great deal of information available, the drug appears to be well tolerated and has a favourable risk profile.

image Sharapova says she has a legal prescription for this medication to treat a heart condition. Wikimedia Commons, CC BY

Only on January 1 this year was mildronate added to the World Anti-Doping Agency’s list of banned substances after it was monitored for a year. The agency collected samples to determine if athletes regularly used the drug.

WADA found evidence of widespread use – more than 180 positive results from a sample of 8,320, which is a positive rate of more than 2%. Most of these results were from periods of competition (not breaks between competition seasons) and more than half were from the strength sport athletes.

WADA monitors substances, develops analytical tests for their detection and finally bans them. These substances are generally drugs that are developed for specific medical concerns. Anabolic steroids are the original template for this, as much of the original research from the 1930s was initially used to help people with various muscle-wasting conditions (such as cancer and HIV/AIDS) or hormonal problems.

Who’s to blame?

Sharapova’s claim is that her prescription for the drug is ongoing, legal and had been maintained since 2006 to treat a magnesium deficiency, diabetes and a congenital heart problem.

So far, not enough information is available to evaluate the likelihood of this claim.

Certainly magnesium deficiency is common enough in sports people, to the extent it is one of the first conditions that would be checked if the athlete reports “unexpected fatigue”. Magnesium deficiency is straightforward to treat with supplemental magnesium. This can be administered by tablet, capsule, injection or even by inhaler in acute cases.

What might be possible at this point is to apply for a therapeutic use exemption, which is a request to use a controlled substance despite banned or restricted status. In this case, the therapeutic use exemption would have to apply retroactively.

The rules here are unclear, as WADA allows a retroactive therapeutic use exemption in cases of:

a) medical emergency

b) extraordinary circumstances, or – and this is very unclear –

c) if they feel it would be “fair” to allow such an exemption.

In other words, if a doctor prescribed mildronate (and that prescription is justified by good medical evidence), Sharapova may have a case.

Failing that, the WADA rules are very clear about banned substances – unless you can conclusively prove you were inadvertently contaminated, your positive test is regarded as the only evidence necessary.

It is possible that Sharapova’s drug use was just a bad oversight on her part, but this may not change the outcome. Professional athletes these days are usually scrupulously careful about their supplement and medication use. This goes doubly for athletes who have a public image or endorsements to lose in the face of drug use claims.

However, they are also often taking a dizzying array of vitamin and mineral support, legal and grey-market performance-enhancers and prescribed/approved medications for ongoing conditions. It could well be difficult to keep track of all of them.

More than anything else, this is a failure of management. A sportsperson is not a pharmacologist, and Sharapova cannot be expected to know the specific pharmacology behind the range of medical and supplemental support she is taking, especially if this is changed or elevated because of injury.

Authors: The Conversation Contributor

Read more http://theconversation.com/maria-sharapovas-positive-drug-test-what-is-it-and-what-does-it-mean-for-her-55927

Writers Wanted

One quarter of Australian 11-12 year olds don't have the literacy and numeracy skills they need


Step-by-Step Process of Filing Bankruptcy in Georgia


The Conversation


Prime Minister Interview with Kieran Gilbert, Sky News

KIERAN GILBERT: Kieran Gilbert here with you and the Prime Minister joins me. Prime Minister, thanks so much for your time.  PRIME MINISTER: G'day Kieran.  GILBERT: An assumption a vaccine is ...

Daily Bulletin - avatar Daily Bulletin

Did BLM Really Change the US Police Work?

The Black Lives Matter (BLM) movement has proven that the power of the state rests in the hands of the people it governs. Following the death of 46-year-old black American George Floyd in a case of ...

a Guest Writer - avatar a Guest Writer

Scott Morrison: the right man at the right time

Australia is not at war with another nation or ideology in August 2020 but the nation is in conflict. There are serious threats from China and there are many challenges flowing from the pandemic tha...

Greg Rogers - avatar Greg Rogers

Business News

AppDynamics Solves Visibility Gap Between Traditional Infrastructure and Cloud Environments

New Full Stack Observability Platform, Integration With Cisco Intersight Workload Optimizer and Cloud Native Visualisation Features Provide Cross Domain Insights and Analytics of Business Perfor...

Hotwire Global - avatar Hotwire Global

Why Your Small Business Should Bulk Buy Hand Sanitiser

As a small business owner, employee and customer safety is at the very top of your priority list. From risk assessments to health and safety officers, appropriate signage and proper briefing...

News Co - avatar News Co

How Phone Number Search In Sydney Can Help Your Business

To run a successful business, keeping track of your company and competitors are the major factors. With a lot of tools, available businesses have options to stay current. One way in which busine...

News Co - avatar News Co

News Co Media Group

Content & Technology Connecting Global Audiences

More Information - Less Opinion